Cleared Traditional

K991299 - MODIFICATION TO CARDIAC STATUS CK-MB/MYOGLOBIN RAPID ONE-STEP TEST, LIFESIGN MI CK-MB/MYOGLOBIN, LIFESIGN CK-MB/MYOGLOBI (FDA 510(k) Clearance)

May 1999
Decision
52d
Days
Class 2
Risk

K991299 is an FDA 510(k) clearance for the MODIFICATION TO CARDIAC STATUS CK-MB/MYOGLOBIN RAPID ONE-STEP TEST, LIFESIGN MI CK-MB/MYOGLOBIN, LIFESIGN CK-MB/MYOGLOBI. This device is classified as a Chromatographic Separation, Cpk Isoenzymes (Class II - Special Controls, product code JHT).

Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on May 28, 1999, 52 days after receiving the submission on April 6, 1999.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1215.

Submission Details

510(k) Number K991299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1999
Decision Date May 28, 1999
Days to Decision 52 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code JHT — Chromatographic Separation, Cpk Isoenzymes
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1215